Synopsis
Following the launch of its 2020 Pharmaceuticals Strategy for Europe, the European Commission (EC) adopted the first draft of a new directive and regulation in April 2023, opening it up to public consultation. This workshop will
- review the new environmental protections offered under the proposed legislation and the associated requirements placed upon pharmaceutical manufacturers to assess the environmental impact of the entire lifecycle of a product, from manufacturing, through use, to disposal, and
- highlight work being carried out in the ETERNAL project to visualise the interconnected system of socio-economic activity of which a typical pharmaceutical lifecycle is comprised, and to locate and assess the impacts of this activity.
Format
Short presentations will introduce both the context and substance of the proposed changes to EU legislation and the emerging results of collaborative research being presented. With the scene set, the second part of the workshop will be driven by dialogue with the audience to capture views both positive and negative on the prospective legislative changes and how new tools for process and system design, and better understanding of the environmental fate and eco-toxicological effects of pharmaceuticals can help those seeking to build compliance into their businesses. (45 minutes estimated duration)
Output
Workshop participants will benefit from a concise update on the key features of an important piece of emerging trans-national legislation and the chance to consider its implications for their own organisations. The perspectives of workshop participants from across the pharmaceuticals value chain will be captured and used by the ETERNAL project to help inform and direct work to produce a roadmap for integrating new scientific knowledge into regulatory risk assessment to target mitigations, modifications, and management strategies, ultimately towards a greener, more sustainable environment.
